Global Rx-360 Consortium Aims To Curb Supply Chain Threats
This article was originally published in The Tan Sheet
Executive Summary
Drug manufacturers formed the Rx-360 consortium as a vanguard in protecting the global supply chain of ingredients for Rx and nonprescription drug products from threats like the heparin adulteration potentially linked to 146 U.S. deaths in 2008